Header Logo
Last Name

Gabriel Pardo

TitleAssociate Member
InstitutionOklahoma Medical Research Foundation
DepartmentArthritis and Clinical Immunology
Address825 N.E. 13th Street
Oklahoma City OK
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pardo G, Jones DE. Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol. 2017 Dec; 264(12):2375-2377. PMID: 29063239.
      View in: PubMed
    2. Pardo G, Jones DE. The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol. 2017 Dec; 264(12):2351-2374. PMID: 28879412.
      View in: PubMed
    3. Fjeldstad C, Pardo G. Immediate Effect of a Service Dog on Walking Speed in Individuals with Multiple Sclerosis and Gait Dysfunction: A Pilot Study. Int J MS Care. 2017 Jan-Feb; 19(1):40-41. PMID: 28243185.
      View in: PubMed
    4. Fjeldstad C, Suárez G, Klingler M, Henney HR, Rabinowicz AL, Pardo G. Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis. Int J MS Care. 2015 Nov-Dec; 17(6):275-83. PMID: 26664333.
      View in: PubMed
    5. Fjeldstad C, Fjeldstad AS, Pardo G. Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study. Int J MS Care. 2015 Sep-Oct; 17(5):215-20. PMID: 26472942; PMCID: PMC4599358.
    6. Yapundich R, Applebee A, Bethoux F, Goldman MD, Hutton GJ, Mass M, Pardo G, Klingler M, Henney HR, Blight AR, Carrazana EJ. Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial. Int J MS Care. 2015 May-Jun; 17(3):138-45. PMID: 26052259; PMCID: PMC4455866.
    7. Schubert RD, Hu Y, Kumar G, Szeto S, Abraham P, Winderl J, Guthridge JM, Pardo G, Dunn J, Steinman L, Axtell RC. IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6. PMID: 25646307; PMCID: PMC4340715.
    8. Kaufman M, Pardo G, Rossman H, Sweetser MT, Forrestal F, Duda P. Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis. J Neurol Sci. 2014 Jun 15; 341(1-2):22-7. PMID: 24731783.
      View in: PubMed
    9. Fjeldstad C, Fjeldstad AS, Weir JP, Pardo G. Association of vitamin D deficiency with RNFL thickness in MS individuals without history of optic neuritis. Mult Scler Relat Disord. 2014 Jul; 3(4):489-93. PMID: 25877061.
      View in: PubMed
    10. Singer B, Wray S, Miller T, Cascione M, Gupta A, Pardo G, Watsky E, Hayward B, Mercer B, Dangond F. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis. Mult Scler Relat Disord. 2012 Apr; 1(2):87-94. PMID: 25876936.
      View in: PubMed
    11. Fjeldstad C, Bemben M, Pardo G. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography. J Clin Neurosci. 2011 Nov; 18(11):1469-72. PMID: 21917458.
      View in: PubMed
    12. Fjeldstad C, Pardo G, Bemben D, Bemben M. Decreased postural balance in multiple sclerosis patients with low disability. Int J Rehabil Res. 2011 Mar; 34(1):53-8. PMID: 20679901.
      View in: PubMed
    13. Zwibel H, Pardo G, Smith S, Denney D, Oleen-Burkey M. A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis. J Neurol. 2011 Mar; 258(3):402-11. PMID: 20922405.
      View in: PubMed
    14. Pardo G, Boutwell C, Conner J, Denney D, Oleen-Burkey M. Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate. J Neurosci Nurs. 2010 Feb; 42(1):40-6. PMID: 20187348.
      View in: PubMed
    15. Fjeldstad C, Frederiksen C, Fjeldstad AS, Bemben M, Pardo G. Arterial compliance in multiple sclerosis: a pilot study. Angiology. 2010 Feb-Mar; 61(1):31-6. PMID: 19497928.
      View in: PubMed
    16. Giovannoni G, Barbarash O, Casset-Semanaz F, Jaber A, King J, Metz L, Pardo G, Simsarian J, Sørensen PS, Stubinski B. Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis. Clin Ther. 2007 Jun; 29(6):1128-45. PMID: 17692727.
      View in: PubMed
    Pardo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description